Citadel Advisors’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Citadel Advisors’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-72,322	Closed	-$2.6M	–	14054
2020 Q4	$2.6M	Sell	72,322 -48,311	-40%	-$1.69M	﹤0.01%	4822
2020 Q3	$3.39M	Buy	120,633 +107,713	+834%	+$3.81M	﹤0.01%	3779
2020 Q2	$560K	Buy	12,920 +3,308	+34%	+$150K	﹤0.01%	6876
2020 Q1	$365K	Sell	9,612 -6,315	-40%	-$246K	﹤0.01%	6984
2019 Q4	$433K	Buy	+15,927	New	+$401K	﹤0.01%	7036

Citadel Advisors's VIE Position: Q1 2021 in Review

Citadel Advisors sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 72,322 shares — an estimated $2.6M sold.

Citadel Advisors first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $3.39M in Q3 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

Citadel Advisors reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Citadel Advisors sold 72,322 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $2.6M.
Citadel Advisors first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Citadel Advisors's Viela Bio, Inc. Common Stock position peaked at $3.39M in Q3 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.